FI961056A0 - Uudet säädetysti vapauttavat helmet ja niitä sisältävä farmaseuttinen valmiste - Google Patents
Uudet säädetysti vapauttavat helmet ja niitä sisältävä farmaseuttinen valmisteInfo
- Publication number
- FI961056A0 FI961056A0 FI961056A FI961056A FI961056A0 FI 961056 A0 FI961056 A0 FI 961056A0 FI 961056 A FI961056 A FI 961056A FI 961056 A FI961056 A FI 961056A FI 961056 A0 FI961056 A0 FI 961056A0
- Authority
- FI
- Finland
- Prior art keywords
- same
- controlled release
- pharmaceutical preparation
- preparation containing
- new beads
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9402422A SE9402422D0 (sv) | 1994-07-08 | 1994-07-08 | New beads for controlled release and a pharmaceutical preparation containing the same |
PCT/SE1995/000676 WO1996001621A1 (en) | 1994-07-08 | 1995-06-07 | New beads for controlled release and a pharmaceutical preparation containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
FI961056A0 true FI961056A0 (fi) | 1996-03-07 |
FI961056A FI961056A (fi) | 1996-05-06 |
Family
ID=20394677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI961056A FI961056A (fi) | 1994-07-08 | 1996-03-07 | Uudet säädetysti vapauttavat helmet ja niitä sisältävä farmaseuttinen valmiste |
Country Status (23)
Country | Link |
---|---|
US (1) | US5783215A (fi) |
EP (1) | EP0723434A1 (fi) |
JP (1) | JPH09502738A (fi) |
CN (1) | CN1134108A (fi) |
AU (1) | AU700949B2 (fi) |
BR (1) | BR9506026A (fi) |
CA (1) | CA2170526A1 (fi) |
CZ (1) | CZ73196A3 (fi) |
EE (1) | EE03280B1 (fi) |
FI (1) | FI961056A (fi) |
HU (1) | HUT75772A (fi) |
IL (1) | IL114448A (fi) |
MX (1) | MX9600858A (fi) |
NO (1) | NO960837D0 (fi) |
NZ (1) | NZ289947A (fi) |
PL (1) | PL313386A1 (fi) |
RU (1) | RU2141822C1 (fi) |
SE (1) | SE9402422D0 (fi) |
SK (1) | SK30396A3 (fi) |
TR (1) | TR199500822A2 (fi) |
TW (1) | TW460300B (fi) |
WO (1) | WO1996001621A1 (fi) |
ZA (1) | ZA955545B (fi) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
FR2758461A1 (fr) * | 1997-01-17 | 1998-07-24 | Pharma Pass | Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation |
CA2230748C (en) * | 1997-03-14 | 2010-08-03 | American Home Products Corporation | Rapamycin formulations for oral administration |
SE9702533D0 (sv) | 1997-07-01 | 1997-07-01 | Astra Ab | New oral formulation |
FR2771291B1 (fr) * | 1997-11-21 | 2000-02-25 | Ethypharm Lab Prod Ethiques | Spheroides, procede de preparation et compositions pharmaceutiques |
UA65607C2 (uk) * | 1998-03-04 | 2004-04-15 | Орто-Макнейл Фармацевтикал, Інк. | Фармацевтична композиція (варіанти) та спосіб її приготування |
CO5070568A1 (es) | 1998-05-22 | 2001-08-28 | Eurand Internatrional Spa | Proceso de aplicacion de capas y aparato para efectuarlo |
SE9803871D0 (sv) * | 1998-11-11 | 1998-11-11 | Pharmacia & Upjohn Ab | Therapeutic method and formulation |
DE19842753A1 (de) * | 1998-09-18 | 2000-03-23 | Bayer Ag | Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung |
US6245913B1 (en) | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
US7863331B2 (en) | 1999-07-09 | 2011-01-04 | Ethypharm | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
FR2795961B1 (fr) | 1999-07-09 | 2004-05-28 | Ethypharm Lab Prod Ethiques | Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation |
EE05191B1 (et) | 1999-11-11 | 2009-08-17 | Pharmacia Ab | Farmatseutiline kompositsioon, mis sisaldab tolterodiini, ja selle kasutamine |
CA2456034A1 (en) * | 2001-08-03 | 2003-02-20 | Takeda Chemical Industries, Ltd. | Sustained-release medicines |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
WO2003053402A1 (en) * | 2001-12-20 | 2003-07-03 | Pharmacia Corporation | Zero-order sustained released dosage forms and method of making the same |
US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
CO5400144A1 (es) | 2002-03-11 | 2004-05-31 | Novartis Ag | Compuestos organicos |
US7022342B2 (en) * | 2002-03-28 | 2006-04-04 | Andrx Corporation, Inc. | Controlled release oral dosage form of beta-adrenergic blocking agents |
AU2003236947A1 (en) * | 2002-06-07 | 2003-12-22 | Ranbaxy Laboratories Limited | Modified release, multiple unit drug delivery systems |
US7803402B2 (en) * | 2002-07-06 | 2010-09-28 | Sanjeev Khandelwal | Pharmaceutical preparations |
FR2842736B1 (fr) * | 2002-07-26 | 2005-07-22 | Flamel Tech Sa | Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s) |
US9107804B2 (en) | 2002-12-10 | 2015-08-18 | Nortec Development Associates, Inc. | Method of preparing biologically active formulations |
CA2515130A1 (en) | 2003-02-05 | 2004-08-26 | Teva Pharmaceutical Industries Ltd. | Method of stabilizing lansoprazole |
WO2004105735A1 (en) * | 2003-05-30 | 2004-12-09 | Ranbaxy Laboratories Limited | Controlled release pharmaceutical compositions of tolterodine and processes for their preparation |
CA2529984C (en) | 2003-06-26 | 2012-09-25 | Isa Odidi | Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
FR2861990B1 (fr) * | 2003-11-10 | 2006-02-10 | Nouveaux Produits Pharma | Comprimes faiblement doses a reseau de polymeres |
US8734850B2 (en) | 2003-11-25 | 2014-05-27 | Flamel Technologies | Oral medicinal product with modified release of at least one active principle in multimicrocapsular form |
WO2005123042A1 (en) * | 2004-06-10 | 2005-12-29 | Glatt Air Techniques, Inc. | Controlled release pharmaceutical formulation |
US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
SI1915137T1 (sl) | 2005-08-10 | 2013-12-31 | Add Advanced Drug Delivery Technologies, Ltd. | Pripravek z nadzorovanim sproščanjem za peroralno dajanje |
US20070141151A1 (en) * | 2005-12-20 | 2007-06-21 | Silver David I | Lansoprazole orally disintegrating tablets |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
ES2593047T3 (es) | 2006-02-03 | 2016-12-05 | Opko Renal, Llc | Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3 |
ATE536864T1 (de) * | 2006-02-24 | 2011-12-15 | Teva Pharma | Metoprololsuccinat tabletten mit verlängerter freisetzung und verfahren für deren herstellung |
EP2007360B1 (en) | 2006-04-03 | 2014-11-26 | Isa Odidi | Controlled release delivery device comprising an organosol coat |
WO2007122478A2 (en) * | 2006-04-20 | 2007-11-01 | Themis Laboratories Private Limited | Multiple unit compositions |
WO2007122015A1 (en) * | 2006-04-21 | 2007-11-01 | Synthon B.V. | Tolterodine beads |
TW200806282A (en) * | 2006-05-05 | 2008-02-01 | Wyeth Corp | Solid dosage formulations |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
ES2670029T3 (es) | 2006-06-21 | 2018-05-29 | Opko Ireland Global Holdings, Ltd. | Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D |
WO2008014175A2 (en) * | 2006-07-28 | 2008-01-31 | Dr. Reddy's Laboratories Ltd. | Granular pharmaceutical compositions |
EP2762132A1 (en) | 2007-04-25 | 2014-08-06 | Cytochroma Inc. | Controlled Release 25-Hydroxyvitamin D |
US20100144684A1 (en) | 2007-04-25 | 2010-06-10 | Proventiv Therapeutics, Inc. | Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease |
DK2148684T3 (da) | 2007-04-25 | 2013-04-22 | Cytochroma Inc | Fremgangsmåde til behandling af vitamin D-insufficiens og -deficiens |
CL2008001970A1 (es) * | 2007-07-03 | 2009-03-27 | Synthon Bv | Perla con un nucleo de celulosa microcristalina, un recubrimiento soluble en agua con un polimero vinil pirrolidina, una capa con tolterodina y un aglutinante, y una capa de liberacion controlada con un poliacrilato; proceso para prepararla; forma de dosificacion, util en trastornos urinarios como vejiga hiperactiva. |
CA2629099A1 (en) * | 2008-04-01 | 2009-10-01 | Pharmascience Inc. | Novel oral controlled release pharmaceutical formulations |
CN106853250A (zh) | 2008-04-02 | 2017-06-16 | 赛特克罗公司 | 用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒 |
JP2012500823A (ja) * | 2008-08-29 | 2012-01-12 | グラクソ グループ リミテッド | 1−イソプロピル−4−{[4−(テトラヒドロ−2h−ピラン−4−イルオキシ)フェニル]カルボニル}ヘキサヒドロ−1h−1,4−ジアゼピンまたはその塩を含んでなる剤形 |
US9078830B2 (en) | 2009-07-31 | 2015-07-14 | Ranbaxy Laboratories Limited | Multi-layered, multiple unit pharmaceutical compositions |
US20140112995A1 (en) * | 2009-07-31 | 2014-04-24 | Ranbaxy Laboratories Limited | Multi-layered, multiple unit pharmaceutical compositions |
WO2011095388A1 (en) | 2010-02-04 | 2011-08-11 | Synthon Bv | Tolterodine bead |
PT2552484T (pt) | 2010-03-29 | 2020-04-03 | Opko Ireland Global Holdings Ltd | Métodos e composições para redução dos níveis de parafróides |
KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 d 방출 제형 |
AU2014246617A1 (en) | 2013-12-23 | 2015-07-09 | Sun Pharmaceutical Industries Limited | Multi-layered, multiple unit pharmaceutical compositions |
SG10201911274TA (en) | 2014-08-07 | 2020-02-27 | Opko Ireland Global Holdings Ltd | Adjunctive therapy with 25-hydroxyvitamin d |
GB201417828D0 (en) | 2014-10-08 | 2014-11-19 | Cereno Scient Ab | New methods and compositions |
EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
RU2744270C2 (ru) * | 2015-12-28 | 2021-03-04 | ЭсЭсПи КО., ЛТД., ДЖАПАН | Прессованный фармацевтический препарат |
IL243707A0 (en) | 2016-01-20 | 2016-05-01 | Galmed Res And Dev Ltd | Treatment to regulate the microbiota in the intestine |
TWI747893B (zh) | 2016-03-28 | 2021-12-01 | 愛爾蘭商歐科愛爾蘭全球控股股份有限公司 | 維生素d治療之方法 |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
CN108272766B (zh) * | 2018-03-21 | 2020-07-07 | 江苏四环生物制药有限公司 | 一种甲钴胺分散迟释片及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK62184D0 (da) * | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
DE3586600T2 (de) * | 1984-02-10 | 1993-02-18 | Benzon Pharma As | Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend. |
SE450087B (sv) * | 1985-10-11 | 1987-06-09 | Haessle Ab | Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial |
US5026560A (en) * | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
FR2610327B1 (fr) * | 1987-01-30 | 1989-08-25 | Charbonnages Ste Chimique | Interpolymere composite a plusieurs couches, son procede de preparation, son application au renforcement de matrices thermoplastiques rigides et compositions renforcees correspondantes |
US4891223A (en) * | 1987-09-03 | 1990-01-02 | Air Products And Chemicals, Inc. | Controlled release delivery coating formulation for bioactive substances |
CA1338596C (en) * | 1988-09-27 | 1996-09-17 | Hiroyoshi Koyama | Granules having core and their production |
US5084287A (en) * | 1990-03-15 | 1992-01-28 | Warner-Lambert Company | Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat |
EP0447168A3 (en) * | 1990-03-16 | 1993-01-07 | Yamanouchi Pharmaceutical Co. Ltd. | Long acting granular pharmaceutical composition |
EP0452862B1 (en) * | 1990-04-18 | 1995-07-19 | Asahi Kasei Kogyo Kabushiki Kaisha | Spherical seed cores, spherical granules and process for production thereof |
-
1994
- 1994-07-08 SE SE9402422A patent/SE9402422D0/xx unknown
-
1995
- 1995-06-07 RU RU96107106A patent/RU2141822C1/ru active
- 1995-06-07 CA CA002170526A patent/CA2170526A1/en not_active Abandoned
- 1995-06-07 BR BR9506026A patent/BR9506026A/pt not_active Application Discontinuation
- 1995-06-07 CN CN95190775A patent/CN1134108A/zh active Pending
- 1995-06-07 US US08/464,773 patent/US5783215A/en not_active Expired - Fee Related
- 1995-06-07 EP EP95926053A patent/EP0723434A1/en not_active Withdrawn
- 1995-06-07 NZ NZ289947A patent/NZ289947A/en unknown
- 1995-06-07 CZ CZ96731A patent/CZ73196A3/cs unknown
- 1995-06-07 AU AU29936/95A patent/AU700949B2/en not_active Ceased
- 1995-06-07 PL PL95313386A patent/PL313386A1/xx unknown
- 1995-06-07 WO PCT/SE1995/000676 patent/WO1996001621A1/en not_active Application Discontinuation
- 1995-06-07 EE EE9600034A patent/EE03280B1/xx unknown
- 1995-06-07 MX MX9600858A patent/MX9600858A/es unknown
- 1995-06-07 HU HU9600575A patent/HUT75772A/hu unknown
- 1995-06-07 SK SK303-96A patent/SK30396A3/sk unknown
- 1995-06-07 JP JP8504247A patent/JPH09502738A/ja active Pending
- 1995-06-15 TW TW084106118A patent/TW460300B/zh active
- 1995-07-04 ZA ZA955545A patent/ZA955545B/xx unknown
- 1995-07-04 IL IL11444895A patent/IL114448A/xx active IP Right Grant
- 1995-07-06 TR TR95/00822A patent/TR199500822A2/xx unknown
-
1996
- 1996-02-29 NO NO960837A patent/NO960837D0/no not_active Application Discontinuation
- 1996-03-07 FI FI961056A patent/FI961056A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
MX9600858A (es) | 1997-06-28 |
EP0723434A1 (en) | 1996-07-31 |
US5783215A (en) | 1998-07-21 |
NO960837L (no) | 1996-02-29 |
IL114448A (en) | 1999-09-22 |
FI961056A (fi) | 1996-05-06 |
CN1134108A (zh) | 1996-10-23 |
CZ73196A3 (en) | 1996-08-14 |
NO960837D0 (no) | 1996-02-29 |
PL313386A1 (en) | 1996-06-24 |
NZ289947A (en) | 1998-07-28 |
AU2993695A (en) | 1996-02-09 |
CA2170526A1 (en) | 1996-01-25 |
TW460300B (en) | 2001-10-21 |
SK30396A3 (en) | 1997-09-10 |
SE9402422D0 (sv) | 1994-07-08 |
JPH09502738A (ja) | 1997-03-18 |
RU2141822C1 (ru) | 1999-11-27 |
BR9506026A (pt) | 1997-10-14 |
AU700949B2 (en) | 1999-01-14 |
ZA955545B (en) | 1996-01-08 |
EE03280B1 (et) | 2000-08-15 |
HU9600575D0 (en) | 1996-07-29 |
WO1996001621A1 (en) | 1996-01-25 |
IL114448A0 (en) | 1995-11-27 |
HUT75772A (en) | 1997-05-28 |
TR199500822A2 (tr) | 1996-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI961056A0 (fi) | Uudet säädetysti vapauttavat helmet ja niitä sisältävä farmaseuttinen valmiste | |
FI943570A0 (fi) | 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita | |
FI973039A (fi) | Uusia farnesyylitransferaasin inhibiittoreita, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia | |
FI941137A0 (fi) | 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi | |
FI953479A (fi) | 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö | |
FI930882A0 (fi) | Farmaceutiska foereningar | |
FI905510A0 (fi) | Nya bensoxazinderivat och dessa innehaollande farmaceutiska blandningar. | |
BR8807263A (pt) | Controlador de irrigacao e sistema de visualizacao para o mesmo | |
FI960483A0 (fi) | Muunnettava koostumus ja menetelmät sen käyttämiseksi | |
FI970095A0 (fi) | Uudet kemialliset yhdisteet, niiden valmistus ja niiden käyttö lääkeaineena | |
FI964641A0 (fi) | Seinämärakenne hyttejä, kojuja, mökkejä ja vastaavia varten | |
FI972186A (fi) | Menetelmä isomaltuloosin ja muiden tuotteiden valmistamiseksi | |
FI931251A0 (fi) | Farmaceutiska foereningar | |
FI960367A0 (fi) | Uusia dialkoksipyridinyylibentsimidatsolijohdannaisia | |
FI941914A0 (fi) | 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö | |
FI923855A (fi) | Katalysaattori ja sen valmistusmenetelmä | |
FI964500A0 (fi) | Matriisijärjestelmä ibuprofeenin transdermaaliseen antoon ja menetelmä sen valmistamiseksi | |
FI913888A (fi) | Nya farmaceutiska sammansaettningar och foerfarande foer framstaellning av desamma. | |
EE03511B1 (et) | Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid | |
FI932863A (fi) | Foerfarande foer framstaellning av nya tienotiazinderivat och deras anvaendning | |
FI972965A0 (fi) | Uusia peptidejä, niiden valmistus ja käyttö | |
FI951155A0 (fi) | Farmaseuttinen valmiste | |
FI950874A0 (fi) | Uudet polyjoditetut yhdisteet, menetelmä niiden valmistamiseksi, niitä sisältävä varjoaine | |
FI923304A (fi) | Nya bearbetbara tiofenbaserade polymerer och kopolymerer, och vaermestabila elledande kompositioner daerav | |
FI972694A0 (fi) | Uusi menetelmä sameridiinin valmistamiseksi |